Sweden's Sleep Cycle Q1 sales drop as subscribers decline; to reorganise, cut some jobs

Sleep Cycle AB (publ)

29/04/2026 06:45

Overview

Sweden sleep health app's Q1 net sales fell 19% yr/yr as subscriber base declined

Adjusted EPS dropped to SEK 0.27 from SEK 0.68 a year earlier

Company to reorganize, with management changes and some job cuts to support transformation

Outlook

Company expects clinical study for sleep apnea screening to complete in September 2026

Sleep Cycle plans organizational changes to drive business areas with greater speed and accountability

2026 described as a year of significant investment for the company

Result Drivers

B2B GROWTH - B2B revenue rose 42% and made up a larger share of total revenue, driven by technology licensing, per CEO Erik Jivmark

SUBSCRIBER DECLINE - Paying subscribers fell to 715k from 904k, contributing to lower net sales

PRODUCT DEVELOPMENT - Co advanced clinical study for sleep apnea screening and launched app features including Sleep Quality Score and ChatGPT integration

Company press release: ID:nMFN9wyBMJ

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
SEK 52.58 mln
Q1 Adjusted EPS
SEK 0.27
Q1 EBIT
SEK 6.73 mln
Q1 EBIT Margin
12.80%


Analyst Coverage

Wall Street's median 12-month price target for Sleep Cycle AB (publ) is SEK30.50, about 65.2% above its April 28 closing price of SEK18.46

The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 9 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)